VBL Therapeutics

About:

VBL Therapeutics is a clinical-stage platform company developing targeted therapies for immune-inflammatory diseases.

Top Investors: European Innovation Council, Israel Innovation Authority, ROTH Capital Partners, Binder & Partners Ventures

Description:

VBL Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases. VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements.

Total Funding Amount:

$58.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Or Yehuda, Tel Aviv, Israel

Founded Date:

2000-01-01

Contact Email:

businessdev(AT)vblrx.com

Founders:

Dror Harats

Number of Employees:

1-10

Last Funding Date:

2021-12-20

IPO Status:

Public

Industries: